Parabolic Drugs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Parabolic Drugs Ltd. on BSE

Search Inside the pdf :

11 Feb 2021

Result

Parabolic Drugs Ltd - 533211 - Outcome Of Board Meeting Held On 11.02.2021 And Intimation Of …

BSE India

Pursuant to Intimation Letter dated 05.02.2021 and Regulation 30 & 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; we furnish herewith the revised Un-audited Financial Results for the Quarter and Nine Months ended on 31st December, 2020. We hereby enclosed the Un-audited financial results for the Quarter and Nine Months ended 31.12.2020 along with the Limited Review Report for the said period. The Meeting was commenced from 05:00 pm and concluded at 06:15 pm This is for your information and records.

pdf

Parabolic Drugs Ltd.

08 Feb 2021

Company Update

Parabolic Drugs Ltd - 533211 - Corporate Insolvency Resolution Process (CIRP)-Public Announcement

BSE India

This is in reference to the captioned matter and as per the Resolution Plan approved by Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') in terms of Section 31(1) of the Insolvency and Bankruptcy Code, 2016 ('IBC') via. order dated 12th January, 2021 inter alia: 1.The entire Paid up, issued and subscribed capital of the Company as at the date of order passed by the NCLT, including Equity Shares listed on the Stock Exchange shall stand cancelled and extinguished without any payout to the shareholders; and 2.The securities of the Company shall stand delisted from the National Stock exchange and Bombay Stock Exchange ('Stock Exchanges') This is for your information and record.

pdf

Parabolic Drugs Ltd.

05 Feb 2021, 06:14PM

Board Meeting

Parabolic Drugs Ltd - 533211 - Board Meeting Intimation for Un-Audited Quarterly Financial Results For The …

BSE India

Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2020 . Pursuant to the letter addressed to your good office on 19th January, 2021 and 22nd January, 2021, whereby, your good self was intimated regarding the approval of resolution plan by Hon'ble National Company Law Tribunal, Chandigarh Bench and as per approved plan Company shall stand delisted from the Stock Exchanges from date of passing order and as per letter dated 25.01.2021 intimated to Stock Exchange, Company had decided to set Friday, 29th January, 2021 as the 'Record Date' for suspension of the Trading of all the Units/scrip's from the Stock Exchange; further, Stock Exchange had decided to set 28th January, 2021 as effective date for suspension of trading of Units/Scrips.

pdf

Parabolic Drugs Ltd.

25 Jan 2021

Corp. Action

Parabolic Drugs Ltd - 533211 - Fixation Of 'Record Date' For Suspension Of Trading Of Units/Scrip

BSE India

Pursuant to above and Clause 5 of Schedule 2 of Resolution plan as approved by the Tribunal, the Company shall stand delisted from Bombay Stock Exchange and National Stock Exchange (jointly called as 'Stock Exchange') from the date of passing the order. Therefore, with reference to the said order, Company had decided to set Friday, 29th January, 2021 as the 'Record Date' for suspension of the Trading of all the Units/scrip's from the Stock Exchange i.e. from the said Record date, no trading of any of the units/scrip shall be conducted under the name of the Parabolic drugs Limited. This information is for all the Interest Investors of the Company and requested you to kindly disseminate the same on immediate basis.

pdf

Parabolic Drugs Ltd.

22 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In terms of Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate received from Link Intime India Private Limited (herein called as 'RTA') for the Quarter ended December 31, 2020. Kindly take the same in your records.

pdf

Parabolic Drugs Ltd.

22 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Corporate Action-Intimation of Delisting

BSE India

Intimation regarding Delisting of Shares and Justification for No Payout to the Shareholders of Parabolic Drugs Limited pursuant to the Resolution Plan approved by Hon'ble NCLT, Chandigarh Bench

pdf

Parabolic Drugs Ltd.

21 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Shareholding for the Period Ended December 31, 2020

BSE India

Parabolic Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

Parabolic Drugs Ltd.

21 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Statement Of Investor Complaints For The Quarter Ended December 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RAJ KUMAR RALHANDesignation :- Any Other

Parabolic Drugs Ltd.

19 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Corporate Action-Intimation of Delisting

BSE India

Intimation regarding Delisting of Shares pursuant to the Resolution plan approved by Hon'ble NCLT, Chandigarh Bench

pdf

Parabolic Drugs Ltd.

16 Jan 2021

Company Update

Parabolic Drugs Ltd - 533211 - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

BSE India

Compliance/Disclosure requirement pursuant to Regulation 30(2) read with clause m of Sub-Part A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Parabolic Drugs Limited which was undergone through Corporate Insolvency Resolution Process (CIRP).

pdf

Is Parabolic Drugs Ltd. worth buying?

11 Votes:

Buy 27.27%

Sell 54.55%

Hold 18.18%